1. Home
  2. DHC vs PCRX Comparison

DHC vs PCRX Comparison

Compare DHC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHC
  • PCRX
  • Stock Information
  • Founded
  • DHC 1998
  • PCRX 2006
  • Country
  • DHC United States
  • PCRX United States
  • Employees
  • DHC N/A
  • PCRX N/A
  • Industry
  • DHC Real Estate Investment Trusts
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DHC Real Estate
  • PCRX Health Care
  • Exchange
  • DHC Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • DHC 629.7M
  • PCRX 1.2B
  • IPO Year
  • DHC N/A
  • PCRX 2011
  • Fundamental
  • Price
  • DHC $2.63
  • PCRX $26.59
  • Analyst Decision
  • DHC Hold
  • PCRX Buy
  • Analyst Count
  • DHC 3
  • PCRX 10
  • Target Price
  • DHC $4.50
  • PCRX $29.30
  • AVG Volume (30 Days)
  • DHC 989.6K
  • PCRX 892.8K
  • Earning Date
  • DHC 02-25-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • DHC 1.54%
  • PCRX N/A
  • EPS Growth
  • DHC N/A
  • PCRX N/A
  • EPS
  • DHC N/A
  • PCRX N/A
  • Revenue
  • DHC $1,477,343,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • DHC N/A
  • PCRX $5.14
  • Revenue Next Year
  • DHC $4.46
  • PCRX $2.44
  • P/E Ratio
  • DHC N/A
  • PCRX N/A
  • Revenue Growth
  • DHC 6.62
  • PCRX 4.40
  • 52 Week Low
  • DHC $2.01
  • PCRX $11.16
  • 52 Week High
  • DHC $4.24
  • PCRX $31.67
  • Technical
  • Relative Strength Index (RSI)
  • DHC 67.74
  • PCRX 77.75
  • Support Level
  • DHC $2.39
  • PCRX $25.06
  • Resistance Level
  • DHC $2.50
  • PCRX $27.10
  • Average True Range (ATR)
  • DHC 0.13
  • PCRX 1.45
  • MACD
  • DHC 0.07
  • PCRX 0.28
  • Stochastic Oscillator
  • DHC 93.85
  • PCRX 86.23

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: